Pfizer recalls quinapril/hydrochlorothiazide tablets with impurity risk
Pfizer recalls 20mg/25mg quinapril and hydrochlorothiazide tablets due to potential impurities that could exceed safe levels. This is a prescription-only product distributed by Greenstone LLC.
Lower-risk recall
CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
Contact the company
What happened, in plain English
Pfizer is recalling prescription quinapril and hydrochlorothiazide tablets that may contain impurities exceeding safe limits. This could pose a health risk if taken regularly over time. Read more at govinfonow.com/recall/35063-pfizer-recalls-quinapril-hydrochlorothiazide-tablets-with-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/35063-pfizer-recalls-quinapril-hydrochlorothiazide-tablets-with-impurity-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0758-2022
Cite this page
“Pfizer recalls quinapril/hydrochlorothiazide tablets with impurity risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35063-pfizer-recalls-quinapril-hydrochlorothiazide-tablets-with-impurity-risk. Based on FDA recall #D-0758-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0758-2022%22&limit=1).
Why it’s dangerous
The tablets may contain N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurities in amounts above the acceptable daily intake limit. These impurities could potentially cause health issues with long-term use, though the risk is not immediate.
Who’s affected
Prescription patients who have the specific 20mg/25mg tablets with NDC 59762-5225-9 and lot FE3714. People taking blood pressure medication who have this exact product are most at risk.
How to tell if you have this one
Check for the specific 20mg/25mg quinapril and hydrochlorothiazide tablets in 90-count bottles with NDC 59762-5225-9 and lot number FE3714. These were distributed by Greenstone LLC in the US.
- Brand
Pfizer- Category
Drug
All 8 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0754-2022 | Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 10 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-3112-23.; Lot FG5379; Exp. 08/2024 | 53 bottles |
| D-0755-2022 | Accuretic (quinapril HCl/hydrochlorothiazide) Tablets 10 mg/12.5 mg 90 tablets bottle, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0222-23; Lot EA6686; Exp. 04/2022 | 160 bottles |
| D-0756-2022 | Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/12.5 mg, 90 tablets bottles, Rx Only Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0220-23.; Lot EA6665, Exp Date 04/2022, Lot CN0640, Exp Date 04/2022 | 1364 bottles |
| D-0757-2022 | Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/25 mg, 90 tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0223-23.; Lot ET6974; Exp. 02/2023 | 265 bottles |
| D-0758-2022 | quinapril and hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-5225-9; Lot FE3714; Exp. 02/2023 | 2442 bottles |
| D-0759-2022 | quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0220-1; Lots DN6931, ED3904 & ED3905; Exp. 03/2023 | 21108 bottles |
| D-0760-2022 | quinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0223-1; Lot DP3414; Exp 02/2023 | 1104 bottles |
| D-0761-2022 | Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20 mg/12.5 mg*, 90 Tablets, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY. NY 10017, Made in Germany, NDC 0071-5212-23 .; Lot FG5381; Exp. 08/2024 | 195 bottles |
What to do — step by step
Check Your Medication
Look for the specific 20mg/25mg quinapril and hydrochlorothiazide tablets with NDC 59762-5225-9 and lot FE3714.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.4 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0758-2022 (March 21, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0758-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.